Posted on 3/7/21
David Nevins Interviews Dr. Matthew Frieman, Associate Professor, University of Maryland School of Medicine
Dr. Frieman’s overall research goal is to create therapeutic interventions for viruses of public health concern by developing
Posted on 2/26/21
Thermo Fisher Scientific Acquires Mesa Biotech
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has completed its previously announced acquisition of Mesa Biotech, Inc., a . . .
Posted on 2/18/21
Safest States During COVID-19 – Updated WalletHub Study
With only 5% of the population fully vaccinated against COVID-19 as of February 17, and vaccination being an essential component for full reopening of the economy, . . .
Posted on 2/10/21
2021's States with the Best & Worst Dental Health - WalletHub Study
With February being National Children’s Dental Health Month and the CDC reporting no COVID-19 transmissions in a clinical dental setting, the personal-finance website WalletHub today released . . .
Posted on 2/8/21
2021’s Healthiest & Unhealthiest Cities in America – WalletHub Study
With health care costs rising and the U.S. facing one of the worst health crises in decades with the COVID-19 pandemic, the personal-finance website WalletHub today . . .
Posted on 2/6/21
Ambu Expands Single-Use Endoscopy Contracts with Two U.S. Group Purchasing Organizations
With the expansion of two existing GPO contracts, Ambu’s position in single-use endoscopy continues to strengthen Ambu Inc., the world leader in single-use endoscopes, announced today . . .
Posted on 2/1/21
Leisure Acquisition Corp. Merge With Ensysce Biosciences
Leisure Acquisition Corp.(NASDAQ: LACQ, LACQU, LACQW), a special purpose acquisition company formed for the purpose of effecting a merger, acquisition or similar business combination, announced today . . .
Posted on 1/27/21
Design Therapeutics Secures $125 Million in Series B
Design Therapeutics, a biotechnology company developing a platform of gene targeted chimera small molecules for the treatment of serious degenerative disorders caused
Posted on 1/26/21
States that Have the Fewest COVID-19 Restrictions – Updated WalletHub Study
With the U.S. starting to open up more but a full reopening only possible once we achieve widespread vaccination, the personal-finance website WalletHub today released updated . . .
Posted on 1/26/21
OncoSec Medical Closes $42.0 Million Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ:ONCS), a late-stage biotechnology company focused on designing, developing and commercializing innovative therapies and proprietary medical approaches to stimulate and guide an anti-tumor . . .
Posted on 1/21/21
OncoSec Medical Prices of $42.0 Million Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ:ONCS), a late-stage biotechnology company focused on designing, developing and commercializing innovative therapies and proprietary medical approaches to stimulate and to guide an . . .
Posted on 1/21/21
OncoSec Medical Proposes Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ:ONCS), a late-stage biotechnology company focused on designing, developing and commercializing innovative therapies and proprietary medical approaches to stimulate and to guide an . . .
Posted on 1/5/21
IconOVir Bio Raises $77 Million in Series A Financing
IconOVir Bio, Inc., a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer,
Posted on 12/10/20
Cities That Need the Most Initial Vaccinations Against COVID-19 – WalletHub Study
With frontline health care workers and other vulnerable populations like the elderly first in line to receive COVID-19 vaccinations, WalletHub today released its report on the . . .
Posted on 12/1/20
IPO Update: Kinnate Biopharma Proposes Terms For $170 Million IPO
SummaryKinnate Biopharma aims to raise $170 million in an IPO.The firm is developing kinase inhibitor-based treatment candidates for various cancers.KNTE has produced promising results in preclinical . . .
Posted on 11/30/20
Kinnate Biopharma Seeks IPO For Kinase Inhibitor Approach
SummaryKinnate Biopharma has filed to raise investment capital in a U.S. IPO.The firm is developing treatments for various cancers using a kinase inhibitor approach.KNTE has produced . . .
Posted on 11/24/20
Sorrento Therapeutics' Multifaceted Plan to Attack COVID-19
Sorrento Therapeutics(NASDAQ:SRNE) arguably has the most diverse set of products for the COVID-19 pandemic. In this video from Motley Fool Live recorded on Nov. 12, executives . . .
Posted on 11/24/20
What Should Sorrento Therapeutics' Investors Look for in the Months Ahead?
In this video from Motley Fool Live recorded on Nov. 12, Henry Ji, chairman, president, and CEO of Sorrento Therapeutics(NASDAQ:SRNE), highlights what investors should expect from . . .
Posted on 11/20/20
Sorrento CEO Henry Ji on How the Company Got Its Start
In this video from Motley Fool Live, which was recorded on Nov. 12, Henry Ji, chairman, president, and CEO of Sorrento Therapeutics(NASDAQ:SRNE), talks about how the . . .
Posted on 11/20/20
How Will Sorrento Therapeutics Deal With the Added COVID-19 Competition?
In this video from Motley Fool Live recorded on Nov. 12, executives from Sorrento Therapeutics (NASDAQ:SRNE) talk about how the company's COVID-19 therapeutic antibodies -- STI-1499 . . .
Posted on 11/10/20
HealthComp Announces Partnership with New Mountain Capital
FRESNO, Calif. & NEW YORK--(BUSINESS WIRE)--HealthComp Holding Company LLC (“HealthComp” or “the Company”), a leading independent Third Party Administrator (TPA) of healthcare benefits for self-funded employers, . . .
Posted on 11/9/20
Ambrx Closes $200M in Crossover Financing
Ambrx Inc., a clinical-stage biopharmaceutical company focused on developing Precision Biologics using an expanded
Posted on 11/9/20
Zentalis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Update
NEW YORK and SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small . . .
Posted on 11/6/20
Here's How Teradata Stock Fell 19% Last Month
What happenedShares of data analytics and database software maker Teradata (NYSE:TDC) fell 19.1% in October 2020, according to data from S&P Global Market Intelligence. When investors . . .
Posted on 11/6/20
Adicet Provides Business Update
MENLO PARK, Calif. and BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta . . .
San Diego
